In the complex landscape o PYY is anorexigenic and inhibits feeding stimuli after a meal, thus preventing excessive energy intake.Read more f biochemical research, few molecules have garnered as much interest as Peptide YY human. As a dedicated enthusiast of peptide research, I have spent conside It isa gut hormone that inhibits both secretin- and cholecystokinin-stimulated pancreatic secretion. This peptide is an endogenous nonselective agonist at NPY Read more rable time analyzing the structural and functional nuances of this fascinating regulatory hormone. To understand its role, one must recognize that it is a peptide that in humans is encoded by the PYY gene.
Structural and Functional Overview
At its core, Peptide YY (often abbreviated as PYY) is a 36-amino acid regulatory gut hormone. Its primary structure is highly conserved, showing significant homology with other members of the pancreatic polypeptide family, such as Neuropeptide Y (NPY).
From a functional perspective, Peptide YY in humans has a role in food ingestion, gut motility and insulin secretion. It is essentially the body's internal signaling system. Research indicates that Peptide YY increases after meal ingestion, acting as a critical feedback mechanism. Because Peptide YY (PYY) is synthesized and secreted from endocrine L-cells of the gastrointestinal tract, it serves as a bridge between caloric intake and systemic energy homeostasis.
Mechanism of Action
One of the most compelling aspects of this molecule is its behavior post-ingestion. It is a peptide released by cells in the ileum and colon in response to eating, and it acts as a chemical messenger. Because it is considered a gut peptide, its influence extends beyond simple digestion. Specifically, it acts as a gut hormone that inhibits both secretin- and cholecystokinin-stimulated pancreatic secretion, which helps modulate the intensity of the digestive response.
Furthermore, PYY is a pleiotropic gut hormone that influences various physiological pathways. It inhibits exocrine pancreatic secretion and has even been shown to possess vasoconstrictory properties. In my own review of the literature, I found it fascinating that Peptide YY is a hormone produced in the gastrointestinal tract in response to food intake, effectively signaling the brain to modulate satiety.
Insights into Satiety and Energy Homeostasis
The primary reason this molecule is a subject of intense study is that PYY is anorexigenic and inhibits feeding stimuli after a meal. By effectively slowing gastric emptying, it prevents excessive energy intake. This is why it has been investigated as a useful drug for human obesity and is a compound being evaluated for the treatment of obesity.
It is important to note that this proces PYY is a 36-amino acid regulatory gut hormonepresent in endocrine cells in the intestine. This peptide acts both as an endocrine and a paracrine agent.Read more s is highly dynamic. Released from cells Peptide YY (PYY), human | Gut Hormone in the ileum and colon in response to feeding, the peptide ensures the body maintains a stable energy balance. Interestingly, it is not just limited to the gut; it is a peptide hormone present in the brain as well, suggesting a complex central and peripheral axis of regulation.
Research Observations and Considerations
While exploring the potential of this molecule, researchers often look at the truncated form, Peptide YY (3-36). This specific variant is recognized as a potent Y2 receptor ago Peptide YY, human nist. In various experimental models, Peptide YY inhibits growth of human breast cancer cells *in vitro* and *in vivo*, though these findings are strictly confined to laboratory research settings and do not constitute clinical guid PYY is anorexigenic and inhibits feeding stimuli after a meal, thus preventing excessive energy intake.Read more ance.
For those interested in the technical sourcing of such compounds, high-purity peptides are often available through specialized suppliers, with prices reflecting the complexity of synthesis (e.g., some research grades are listed at approximately £605.00).
Summary of Key Characteristics
* Molecular Length: 36-amino acid chain.
* Primary Source: Endocrine L-cells of the distal gastrointestinal tract.
* Biological Trigger: Caloric ingestion (fat and carbohydrate).
* Regulatory Role: Modulation of satiety, insulin secretion, Peptide YY (human) | 118997-30-1 | PYY (1-36) and pancreatic activity.
As we continue to explore the intricate mechanisms of human physiology, the study of how Peptide YY (PYY) coordinates with other endocrine signals remains a cornerstone of metabolic research. Understanding these pathways provides a deeper appreciation for how the human body maintains i Peptide YY (PYY), human | Gut Hormone ts internal equilibrium.